|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-06
|
$374,097
|
$56,115
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Novel Approach for the Routine Screening for Ovarian Cancer
|
1R01CA164940-01A1
|
$321,198
|
$321,198
|
PANNELL, LEWIS
|
UNIVERSITY OF SOUTH ALABAMA
|
|
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
|
2R44CA139841-02A1
|
$633,309
|
$158,327
|
PRABHAKARPANDIAN, BALABHASKAR
|
CFD RESEARCH CORPORATION
|
|
A Novel Nanocoaxial Biosensor for Detection of Cancer Biomarkers
|
5R21CA137681-03
|
$231,123
|
$231,123
|
CHILES, THOMAS
|
BOSTON COLLEGE
|
|
A Role for Fatty Acid Binding Protein 4 in Ovarian Cancer Metastasis
|
1F32CA168309-01
|
$53,942
|
$53,942
|
Nieman, Kristin
|
UNIVERSITY OF CHICAGO
|
|
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc
|
5R01CA134424-04
|
$398,474
|
$398,474
|
KOSTUK, RAYMOND
|
UNIVERSITY OF ARIZONA
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
1R01CA168900-01
|
$332,000
|
$166,000
|
Powell, Daniel
|
UNIVERSITY OF PENNSYLVANIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$62,924
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$309,002
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Adaptations and methodologies for enhanced identification of lead compounds
|
ZIABC011468
|
$422,412
|
$211,206
|
Gustafson, Kirk
|
CCR (NCI)
|
|
Addressing Psychosocial Disparities in Rural Hispanic Cancer Survivors
|
5K01CA154938-02
|
$139,976
|
$34,994
|
CEBALLOS, RACHEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adherence to Cancer Risk Management Among Unaffected BRCA1/2Mutation Carriers
|
5R03CA157212-02
|
$84,884
|
$42,442
|
Buchanan, Adam
|
DUKE UNIVERSITY
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-04
|
$381,617
|
$190,809
|
Brentjens, Renier
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
An adenoviral/piggyBac hybrid system to accelerate cancer gene validation(PQ #9)
|
1R21CA170195-01
|
$164,213
|
$164,213
|
Dupuy, Adam
|
UNIVERSITY OF IOWA
|
|
An integrated systems biology approach for ovarian cancer biomarker discovery
|
5U01CA152755-03
|
$190,288
|
$190,288
|
DIAMANDIS, ELEFTHERIOS
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Analysis of BRCA1 recombination functions
|
5R01CA095175-09
|
$295,223
|
$147,612
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Antibody directed delivery of short interfering RNA for the treatment of ovarian
|
1K08CA163603-01A1
|
$170,631
|
$170,631
|
PALANCA-WESSELS, MARIA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Antibody Therapy of Cancer
|
ZIABC010891
|
$518,195
|
$25,910
|
Ho, Mitchell
|
CCR (NCI)
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
2R01CA092160-11
|
$302,203
|
$99,727
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Antiprogestin therapy for ovarian cancer
|
1R15CA164622-01
|
$425,596
|
$425,596
|
Telleria, Carlos
|
UNIVERSITY OF SOUTH DAKOTA
|
|
Apoptosis Inducing to Enhance Tumor Targeting
|
3R44CA103133-04S1
|
$50,000
|
$25,000
|
LU, ZE
|
OPTIMUM THERAPEUTICS, LLC
|
|
Applied Molecular Pathology Laboratory
|
ZICBC011257
|
$168,894
|
$16,889
|
Hewitt, Stephen
|
CCR (NCI)
|
|
ARHI (DIRAS 3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-04
|
$306,953
|
$306,953
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$3,750
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$7,192
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$197,691
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Array Microscope Assay for Cancer Cell Mechanics
|
5R33CA155618-02
|
$309,109
|
$154,555
|
SUPERFINE, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Assessment of Screening Modalities for Gynecologic Cancers
|
ZIA CP010126-10495
|
$13,118
|
$6,559
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Atlantic Breast and Gynecologic Clinical Validation Center
|
5U01CA084955-13
|
$479,070
|
$119,768
|
Marks, Jeffrey
|
DUKE UNIVERSITY
|
|
B7-H1 Signaling in Ovarian Cancer
|
1R01CA164122-01A1
|
$310,040
|
$186,024
|
Curiel, Tyler
|
UNIV OF TX HSC, SA
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIGBC010856
|
$14,609,987
|
$730,499
|
Custer, Mary
|
CCR (NCI)
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S1
|
$41,433
|
$829
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-06S2
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-06
|
$2,934,758
|
$58,695
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
BCDDF: Breast cancer detection demonstration project followup study - I
|
ZIA CP010182-01030
|
$49,058
|
$9,812
|
Schairer, Catherine
|
DCEG (NCI)
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-11S1
|
$140,000
|
$7,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-11
|
$771,835
|
$38,592
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biobehavioral Influences and the Ovarian Tumor Microenvironment
|
3R01CA140933-04S1
|
$43,680
|
$43,680
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biobehavioral Influences and the Ovarian Tumor Microenvironment
|
5R01CA140933-04
|
$524,647
|
$524,647
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$80,656
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bioinformatic Tools in Cancer Research
|
ZIHBC010470
|
$161,950
|
$8,097
|
Buetow, Kenneth
|
CCR (NCI)
|
|
Biomedical Applications of Expanded Porphyrins
|
2R01CA068682-21A1
|
$319,550
|
$319,550
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Biomolecular probes for imaging protease activities
|
5R21CA159232-02
|
$158,369
|
$79,185
|
DAUGHERTY, PATRICK
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
|
Biophotonics Noninvasive Detection of Ovarian Cancer
|
5R21CA156944-02
|
$316,438
|
$316,438
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
1R01CA157481-01A1
|
$344,461
|
$344,461
|
Bhattacharya, Resham
|
MAYO CLINIC
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
5R01CA136512-04
|
$511,599
|
$127,900
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-14
|
$2,522,927
|
$252,293
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Breast and Ovary Cancer Clinical Validation Center
|
5U01CA152637-03
|
$973,064
|
$486,532
|
Li, Christopher
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$472,022
|
$70,803
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
|
5R01CA129142-04
|
$550,522
|
$275,261
|
KINNEY, ANITA
|
UNIVERSITY OF UTAH
|
Total relevant funding to Ovarian Cancer for this search: $111,657,265
|